fda status of bpc 157 2024 FDA's Overreach on Compounded Peptides BPC-157 FDA Approval Status 2026:
Description
Dosed at 500 mcg daily, its non-hormonal, requiring no Post-Cycle Therapy (PCT), making it a safe choice for recovery from injuries, workouts, or joint stress

doi:10.1111/1753-6405.12061 Moons P, Luyckx K, Thomet C, et al

All products are intended solely for laboratory utilization
[Google Scholar] 553

A limitation of this study is the limited timeframe of 6 weeks
